IRIS
IMBRICI, Paola
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.847
AS - Asia 3.059
EU - Europa 2.089
SA - Sud America 820
AF - Africa 103
OC - Oceania 5
Continente sconosciuto - Info sul continente non disponibili 3
Totale 12.926
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.733
SG - Singapore 1.237
BR - Brasile 671
CN - Cina 617
IT - Italia 446
HK - Hong Kong 376
SE - Svezia 310
DE - Germania 294
RU - Federazione Russa 264
VN - Vietnam 230
FR - Francia 189
FI - Finlandia 148
BD - Bangladesh 145
GB - Regno Unito 142
UA - Ucraina 135
IN - India 110
ID - Indonesia 70
AR - Argentina 56
CA - Canada 44
MX - Messico 41
TR - Turchia 38
NL - Olanda 34
IQ - Iraq 32
BE - Belgio 29
PK - Pakistan 27
ZA - Sudafrica 26
SA - Arabia Saudita 25
EC - Ecuador 23
JP - Giappone 23
PL - Polonia 21
MA - Marocco 17
TN - Tunisia 17
AT - Austria 15
VE - Venezuela 15
CO - Colombia 14
ES - Italia 14
UZ - Uzbekistan 14
CL - Cile 13
PH - Filippine 13
PY - Paraguay 12
AE - Emirati Arabi Uniti 11
MY - Malesia 11
NP - Nepal 11
EG - Egitto 9
CI - Costa d'Avorio 8
IE - Irlanda 8
KZ - Kazakistan 8
CR - Costa Rica 7
KE - Kenya 7
BO - Bolivia 6
CZ - Repubblica Ceca 6
DZ - Algeria 6
JO - Giordania 6
OM - Oman 6
TW - Taiwan 6
LB - Libano 5
PE - Perù 5
PS - Palestinian Territory 5
PT - Portogallo 5
TH - Thailandia 5
AL - Albania 4
AU - Australia 4
CH - Svizzera 4
ET - Etiopia 4
IL - Israele 4
KR - Corea 4
RS - Serbia 4
GE - Georgia 3
HN - Honduras 3
KG - Kirghizistan 3
LV - Lettonia 3
UY - Uruguay 3
AZ - Azerbaigian 2
BB - Barbados 2
BH - Bahrain 2
DK - Danimarca 2
DM - Dominica 2
DO - Repubblica Dominicana 2
IR - Iran 2
JM - Giamaica 2
LT - Lituania 2
RO - Romania 2
SN - Senegal 2
SY - Repubblica araba siriana 2
TT - Trinidad e Tobago 2
XK - ???statistics.table.value.countryCode.XK??? 2
AM - Armenia 1
AO - Angola 1
AW - Aruba 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
BN - Brunei Darussalam 1
BT - Bhutan 1
BY - Bielorussia 1
BZ - Belize 1
CV - Capo Verde 1
CY - Cipro 1
EU - Europa 1
GN - Guinea 1
GP - Guadalupe 1
Totale 12.906
Salva come PNG Salva come JPEG
Città #
Fairfield 738
Ashburn 638
Singapore 609
Woodbridge 608
San Jose 457
Houston 455
Chandler 431
Hong Kong 371
Jacksonville 320
Seattle 278
Cambridge 269
Nyköping 257
Ann Arbor 208
Wilmington 207
Beijing 184
Lauterbourg 127
Dallas 114
Lawrence 102
Roxbury 99
Bari 91
New York 90
Nanjing 89
Los Angeles 86
Inglewood 81
Council Bluffs 77
Des Moines 70
Ho Chi Minh City 63
Boardman 55
Jakarta 53
Helsinki 52
Buffalo 44
Santa Clara 44
Hanoi 43
São Paulo 42
Milan 35
San Diego 35
London 34
Princeton 32
Falkenstein 31
Moscow 29
Dong Ket 28
Nanchang 27
Brooklyn 26
Brussels 25
Chicago 25
Hebei 25
Munich 25
Shenyang 25
Paris 23
Tokyo 22
Pune 21
Chennai 20
Rio de Janeiro 20
Rome 18
Warsaw 17
Brasília 16
Frankfurt am Main 16
Jiaxing 16
Johannesburg 16
Mexico City 16
Nuremberg 16
Turku 16
Denver 15
Atlanta 14
Baghdad 14
Jeddah 14
Montreal 14
Dhaka 13
The Dalles 13
Washington 13
Ankara 12
Columbus 12
Guangzhou 12
Naples 12
Tashkent 12
Tianjin 12
Toronto 12
Haiphong 11
Belo Horizonte 10
Curitiba 10
Dearborn 10
Orem 10
Salvador 10
Taranto 10
Vienna 10
Boston 9
Changsha 9
Guayaquil 9
Norwalk 9
Poplar 9
Shanghai 9
Stockholm 9
Tunis 9
Abidjan 8
Biên Hòa 8
Casablanca 8
Dublin 8
Düsseldorf 8
Lahore 8
Porto Alegre 8
Totale 8.510
Salva come PNG Salva come JPEG
Nome #
The analysis of myotonia congenita mutations discloses functional clusters of amino acids within CBS2 domain and C-terminal peptide of ClC-1 channel 285
ATP Sensitive Potassium Channels in the Skeletal Muscle Function: Involvement of the KCNJ11(Kir6.2) Gene in the Determination of Mechanical Warner Bratzer Shear Force 227
ClC-1 chloride channels: state-of-the-art research and future challenges 219
Multidisciplinary study of a new ClC-1 mutation causing myotonia congenita: a paradigm to understand and treat ion channelopathies 209
Mapping ligand binding pockets in ClC-1 channels through an integrated in silico and experimental approach using anthracene-9-carboxylic acid and niflumic acid 207
Pharmacogenetics of myotonic hNav1.4 sodium channel variants situated near the fast inactivation gate 198
Clinical, Molecular, and Functional Characterization of CLCN1 Mutations in Three Families with Recessive Myotonia Congenita 196
ClC-1 mutations in myotonia congenita patients: insights into molecular gating mechanisms and genotype-phenotype correlation 186
Characterization of Student Drinking Behaviors at the Beginning of the First Academic Year at One University in Southern Italy 182
A large cohort of myotonia congenita probands: novel mutations and a high-frequency mutation region in exons 4 and 5 of the CLCN1 gene. 176
Ion channels in drug discovery and safety pharmacology 176
Kidney CLC-K Chloride Channels Show Differential Pharmacological Profiles Depending on the Heterologous Expression System 168
Coexistence of CLCN1 and SCN4A mutations in one family suffering from myotonia 165
A novel KCNA1 mutation in a patient with paroxysmal ataxia, myokymia, painful contractures and metabolic dysfunctions 160
Safinamide's potential in treating nondystrophic myotonias: Inhibition of skeletal muscle voltage-gated sodium channels and skeletal muscle hyperexcitability in vitro and in vivo 154
Chaperone activity of niflumic acid on ClC-1 chloride channel mutants causing myotonia congenita 153
Translational approach to address therapy in myotonia permanens due to a new SCN4A mutation 146
Changes in Expression and Cellular Localization of Rat Skeletal Muscle ClC-1 Chloride Channel in Relation to Age, Myofiber Phenotype and PKC Modulation 144
Alteration of stim1/orai1-mediated soce in skeletal muscle: Impact in genetic muscle diseases and beyond 142
Kv1.1 knock-in ataxic mice exhibit spontaneous myokymic activity exacerbated by fatigue, ischemia and low temperature 141
Andersen-Tawil syndrome: New potassium channel mutations and possible phenotypic variation 141
pH Dependence of the inwardly rectifying potassium channel, Kir5.1, and localization in renal tubular epithelia 140
Dysfunction of the brain calcium channel CaV2.1 in absence epilepsy and episodic ataxia 135
Therapeutic approaches to genetic ion channelopathies and perspectives in drug discovery 134
Pharmacovigilance database search discloses ClC-K channels as a novel target of the AT1 receptor blockers valsartan and olmesartan 130
Human ether-à-go-go-related potassium channel: exploring SAR to improve drug design 129
A Novel KCNA1 Mutation Identified in an Italian Family Affected by Episodic Ataxia Type 1. 127
Novel phenotype associated with a mutation in the KCNA1(Kv1.1) gene 125
Contributions of the central hydrophobic residue in the PXP motif of Voltage-Dependent K+ Channels to S6 flexibility and Gating Properties 122
Functional characterization of ClC-1 mutations from patients affected by recessive myotonia congenita presenting with different clinical phenotypes. 122
Increased sarcolemma chloride conductance as one of the mechanisms of action of carbonic anhydrase inhibitors in muscle excitability disorders 119
Functional characterization of a C-terminal Nav1.4 mutation found in a patient presenting with myotonia and congenital myasthenia syndrome 118
A novel kcna2 variant in a patient with non-progressive congenital ataxia and epilepsy: Functional characterization and sensitivity to 4-aminopyridine 118
Altered functional properties of a missense variant in the TRESK K+ channel (KCNK18) associated with migraine and intellectual disability 117
Dysfunction of the brain calcium channel CaV2.1 in absence epilepsy and episodic ataxia—authors’ response 116
Autism with seizure and intellectual disability: possible causative role of gain-of-function of the Inwardly-Rectifying K+ Channel Kir4.1 115
Differential pH sensitivity of Kir4.1 and Kir4.2 potassium channels and their modulation by heteropolymerisation with Kir5.1 114
Mutations in the KCNA1 gene associated with episodic ataxia type-1 syndrome impair heteromeric voltage-gated K+ channel function 113
Contributions of the central hydrophobic residue in the PXP motif of Voltage-Dependent K+ Channels to S6 flexibility and Gating Properties 113
Mutations in the KCNA1 gene associated with episodic ataxia type-1 syndrome impair heteromeric voltage-gated K+ channel function 110
Kidney CLC-K chloride channels inhibitors: structure-based studies and efficacy in hypertension and associated CLC-K polymorphisms. 110
Episodic Ataxias as Ion Channel Diseases. 109
Kv1.1 channelopathies: Pathophysiological mechanisms and therapeutic approaches 109
Skeletal muscle ClC-1 chloride channels in health and diseases 109
The Kir5.1 Potassium Channel is an Important Determinant of Neuronal PCO2/pH Sensitivity. 108
Functional Study of Novel Bartter's Syndrome Mutations in ClC-Kb and Rescue by the Accessory Subunit Barttin Toward Personalized Medicine 108
All atom molecular dynamics simulation of the K+ Channel Chimera Kv1.2/2.1 106
Involvement of Barttin Subunit in Pharmacological Potentiation of CLC-K Channels Expressed in Xenopus Oocytes 106
Late-onset episodic ataxia type 2 due to an in-frame insertion in CACNA1A 105
Ion channels gene expression analysis in myotonia congenita patients carrying ClC-1 chloride channel mutations 105
Pathomechanisms of a CLCN1 Mutation Found in a Russian Family Suffering From Becker's Myotonia 104
KIDNEY CLC-K CHLORIDE CHANNELS SHOW DIFFERENTIAL PHARMACOLOGICAL PROFILES DEPENDING ON THE HETEROLOGOUS EXPRESSION SYSTEM 103
Role of receptor protein tyrosine phosphatase α (RPTPα) and tyrosine phosphorylation in the serotonergic inhibition of voltage-dependent potassium channels 103
I-J loop involvement in the pharmacological profile of CLC-K channels expressed in Xenopus oocytes 102
Gain-of-Function STIM1 L96V Mutation Causes Myogenesis Alteration in Muscle Cells From a Patient Affected by Tubular Aggregate Myopathy 102
Ion channels as biomarkers of altered myogenesis in myofiber precursors of Duchenne muscular dystrophy 101
Identification of a new de novo mutation underlying regressive episodic ataxia type I 101
Blockers of Skeletal Muscle Nav1.4 Channels: From Therapy of Myotonic Syndrome to Molecular Determinants of Pharmacological Action and Back. 99
The Episodic Ataxia Type 1 Mutation F184C Alters the Zn2+ Modulation of the Human Kv1.4-Kv1.1/Kvb1 Channel 99
Premature stop codons in a facilitating EF-hand splice variant of CaV2.1 cause episodic ataxia type 2 99
Dapagliflozin protects the kidney in a non-diabetic model of cardiorenal syndrome 98
Targeting kidney CLC-K channels: pharmacological profile in a human cell line versus Xenopus oocytes 98
Effects of Episodic Ataxia-Associated Mutations on hKv1.4 1.1/Kvbeta1 channels 97
Paving the way for Bartter syndrome type 3 drug discovery: a hope from basic research 97
Clinical and Functional Study of a De Novo Variant in the PVP Motif of Kv1.1 Channel Associated with Epilepsy, Developmental Delay and Ataxia 96
Branched-chain amino acids and L-alanine supplementation ameliorate calcium dyshomeostasis in sarcopenia: New insights for nutritional interventions 94
Musculoskeletal Features without Ataxia Associated with a Novel de novo Mutation in KCNA1 Impairing the Voltage Sensitivity of Kv1.1 Channel 94
Functional Characterization of an Episodic Ataxia Type-1 Mutation Occurring in the S1 Segment of hKv1.1 Channels. 92
Role of inwardly-rectifying potassium channels Kir5.1 in learning and memory processes in a mouse knock-out model 91
Trace amines depress D2-autoreceptor-mediated responses on midbrain dopaminergic cells. 90
Episodic Ataxia Type 1 Mutations Affect Fast Inactivation of K+ Channels by a Reduction in Either Subunit Surface Expression or Affinity for Inactivation Domain 90
The emerging role of the inwardly rectifying K + channels in autism spectrum disorders and epilepsy 87
Episodic Ataxia Type 1 Mutation F184C Alters Zn2+-Induced Modulation of the Human K+ Channel Kv1.4-Kv1.1/Kvb1.1 86
Therapeutic Approaches to Tuberous Sclerosis Complex: From Available Therapies to Promising Drug Targets 83
Natural ClC-1 mutations causing myotonia congenita reduce sensitivity to 9-AC 83
The Biallelic Inheritance of Two Novel SCN1A Variants Results in Developmental and Epileptic Encephalopathy Responsive to Levetiracetam 82
Differential pH-sensitivity of Kir4.1 and Kir4.2 and modulation by heteropolymerisation with Kir5.1 82
Copertina della rivista Neuroscience 157 (3). A novel mutation identified in an Italian family displaying episodic ataxia, neuromyotonia and epilepsy 81
Modification by ageing of the tetrodotoxin-sensitive sodium channels in rat skeletal muscle fibres 80
Major channels involved in neuropsychiatric disorders and therapeutic perspectives 80
Coexistence of SCN4A and CLCN1 mutations in a family with atypical myotonic features: A clinical and functional study 79
The neurobiology of episodic ataxia type 1: a Shaker-like K+ channel disorder. 78
Sarcoplasmic Reticulum Ca2+ Buffer Proteins: A Focus on the Yet-To-Be-Explored Role of Sarcalumenin in Skeletal Muscle Health and Disease 78
Electromechanical coupling of the Kv1.1 voltage-gated K+ channel is fine-tuned by the simplest amino acid residue in the S4-S5 linker 77
Brugada Syndrome: More than a Monogenic Channelopathy 76
The Episodic Ataxia Type 1 Mutation F184C Alters the Zn2+ Modulation of the Human Kv1.4-Kv1.1/Kvbeta1 Channel 76
Episodic ataxia type 1 mutations cause loss-of-function impairments of heteromeric channels formed by the Kv1.4 and Kv1.1 subunits 75
Modulation of delayed rectifier K+ channels by 5HT2c receptors 75
Novel mutations of Kir2.1 underlying Andersen’s syndrome are non-functional and have a dominant negative effect on the wild –type allele 75
Functional Properties of Voltage-Gated Potassium Channels Probed with Methanethiosulfonate Reagents 75
Identification and functional characterization of a novel mutation in the KCNA1 gene of a Sicilian family affected by episodic ataxia type 1 74
Modulation of hKv 1.1 and hKv 1.2 voltage gating and C-type inactivation by 5-HT2C receptors 73
Pleiotropic Effects of Direct Oral Anticoagulants in Chronic Heart Failure and Atrial Fibrillation: Machine Learning Analysis 73
Mutations in MYBPC3 and MYH7 in Association with Brugada Type 1 ECG Pattern: Overlap between Brugada Syndrome and Hypertrophic Cardiomyopathy? 72
Genetic inactivation of Kcnj16 identifies Kir5.1 as an important determinant of neuronal PCO2/pH sensitivity 72
Gain-of-function of the inwardly rectifying K+ channel Kir4.1 contributes to autism with seizures and intellectual disability 70
Biophysical Aspects of Neurodegenerative and Neurodevelopmental Disorders Involving Endo-/Lysosomal CLC Cl-/H+ Antiporters 69
Role of the S1 segment in the voltage-dependent gating of Kv1.1 channels revealed by naturally occurring pathogenic mutations 69
Effects of sacubitril-valsartan on aging-related cardiac dysfunction 68
Gating properties of human heteromeric voltage-gated potassium channels and effects of episodic ataxia type-1 mutations 68
Totale 11.433
Salva come PNG Salva come JPEG
Categoria #
all - tutte 55.491
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 55.491
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202192 0 0 0 0 0 0 0 0 0 0 0 92
2021/2022818 34 110 7 45 25 52 35 41 45 64 162 198
2022/20231.187 157 123 101 106 117 160 22 125 185 25 35 31
2023/2024415 26 80 27 37 39 101 6 15 11 29 9 35
2024/20252.169 54 15 170 81 76 223 229 202 131 111 272 605
2025/20264.613 577 199 378 457 529 267 576 151 598 457 247 177
Totale 13.401